These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 20015866

  • 21. Specificity of platinum-DNA adduct repair.
    Chaney SG, Vaisman A.
    J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
    [Abstract] [Full Text] [Related]

  • 22. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
    Kasparkova J, Novakova O, Najajreh Y, Gibson D, Perez JM, Brabec V.
    Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
    [Abstract] [Full Text] [Related]

  • 23. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases.
    Yasui M, Suenaga E, Koyama N, Masutani C, Hanaoka F, Gruz P, Shibutani S, Nohmi T, Hayashi M, Honma M.
    J Mol Biol; 2008 Apr 04; 377(4):1015-23. PubMed ID: 18304575
    [Abstract] [Full Text] [Related]

  • 24. DNA oligonucleotide duplexes containing intramolecular platinated cross-links: energetics, hydration, sequence, and ionic effects.
    Kankia BI, Soto AM, Burns N, Shikiya R, Tung CS, Marky LA.
    Biopolymers; 2002 Nov 05; 65(3):218-27. PubMed ID: 12228927
    [Abstract] [Full Text] [Related]

  • 25. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.
    Li L, Liu X, Glassman AB, Keating MJ, Stros M, Plunkett W, Yang LY.
    Cancer Res; 1997 Apr 15; 57(8):1487-94. PubMed ID: 9108450
    [Abstract] [Full Text] [Related]

  • 26. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
    Vaisman A, Masutani C, Hanaoka F, Chaney SG.
    Biochemistry; 2000 Apr 25; 39(16):4575-80. PubMed ID: 10769112
    [Abstract] [Full Text] [Related]

  • 27. Effect of single DNA lesions on in vitro replication with DNA polymerase III holoenzyme. Comparison with other polymerases.
    Belguise-Valladier P, Maki H, Sekiguchi M, Fuchs RP.
    J Mol Biol; 1994 Feb 11; 236(1):151-64. PubMed ID: 8107100
    [Abstract] [Full Text] [Related]

  • 28. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization.
    Suo Z, Lippard SJ, Johnson KA.
    Biochemistry; 1999 Jan 12; 38(2):715-26. PubMed ID: 9888812
    [Abstract] [Full Text] [Related]

  • 29. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR.
    Cancer Res; 1992 Jul 15; 52(14):3857-64. PubMed ID: 1617660
    [Abstract] [Full Text] [Related]

  • 30. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
    Kane SA, Lippard SJ.
    Biochemistry; 1996 Feb 20; 35(7):2180-8. PubMed ID: 8652559
    [Abstract] [Full Text] [Related]

  • 31. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
    Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, Chaney SG.
    Biochemistry; 2003 Feb 18; 42(6):1777-88. PubMed ID: 12578393
    [Abstract] [Full Text] [Related]

  • 32. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
    Ouzon-Shubeita H, Baker M, Koag MC, Lee S.
    Biochem J; 2019 Feb 28; 476(4):747-758. PubMed ID: 30709915
    [Abstract] [Full Text] [Related]

  • 33. Protein interactions with platinum-DNA adducts: from structure to function.
    Chaney SG, Campbell SL, Temple B, Bassett E, Wu Y, Faldu M.
    J Inorg Biochem; 2004 Oct 28; 98(10):1551-9. PubMed ID: 15458816
    [Abstract] [Full Text] [Related]

  • 34. Relationships between cisplatin-induced adducts and DNA strand-breaks, mutation and recombination in vivo in somatic cells of Drosophila melanogaster, under different conditions of nucleotide excision repair.
    García Sar D, Aguado L, Montes Bayón M, Comendador MA, Blanco González E, Sanz-Medel A, Sierra LM.
    Mutat Res; 2012 Jan 24; 741(1-2):81-8. PubMed ID: 22108251
    [Abstract] [Full Text] [Related]

  • 35. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells.
    Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AM.
    Biochemistry; 1995 Jul 04; 34(26):8474-80. PubMed ID: 7599137
    [Abstract] [Full Text] [Related]

  • 36. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ.
    Biochemistry; 1996 Aug 06; 35(31):10004-13. PubMed ID: 8756462
    [Abstract] [Full Text] [Related]

  • 37. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
    Kostrhunova H, Vrana O, Suchankova T, Gibson D, Kasparkova J, Brabec V.
    Chem Res Toxicol; 2010 Nov 15; 23(11):1833-42. PubMed ID: 20939593
    [Abstract] [Full Text] [Related]

  • 38. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
    Burstyn JN, Heiger-Bernays WJ, Cohen SM, Lippard SJ.
    Nucleic Acids Res; 2000 Nov 01; 28(21):4237-43. PubMed ID: 11058123
    [Abstract] [Full Text] [Related]

  • 39. The formation and persistence of carboplatin-DNA adducts in rats.
    Blommaert FA, Michael C, van Dijk-Knijnenburg HC, Schornagel JH, den Engelse L, Fichtinger-Schepman AM.
    Cancer Chemother Pharmacol; 1996 Nov 01; 38(3):273-80. PubMed ID: 8646803
    [Abstract] [Full Text] [Related]

  • 40. Spectrum of DNA--platinum adduct recognition by prokaryotic and eukaryotic DNA-dependent RNA polymerases.
    Corda Y, Job C, Anin MF, Leng M, Job D.
    Biochemistry; 1993 Aug 24; 32(33):8582-8. PubMed ID: 7689335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.